2011
DOI: 10.1016/j.athoracsur.2010.11.068
|View full text |Cite
|
Sign up to set email alerts
|

n-3 Polyunsaturated Fatty Acids After Coronary Artery Bypass Grafting

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 25 publications
0
12
0
Order By: Relevance
“…A recent study in patients after coronary artery bypass surgery reported by Benedetto et al found that in those prescribed omega-3 fatty acids at discharge, 2.5-year mortality was reduced by almost 50% 43 . Higher plasma EPA levels (caused by 1.8 g/d EPA supplementation for 5 years) were also associated with reduced major cardiac events in the Japan EPA Lipid Intervention Study 44 .…”
Section: Discussionmentioning
confidence: 97%
“…A recent study in patients after coronary artery bypass surgery reported by Benedetto et al found that in those prescribed omega-3 fatty acids at discharge, 2.5-year mortality was reduced by almost 50% 43 . Higher plasma EPA levels (caused by 1.8 g/d EPA supplementation for 5 years) were also associated with reduced major cardiac events in the Japan EPA Lipid Intervention Study 44 .…”
Section: Discussionmentioning
confidence: 97%
“…The conflicting conclusions from observational studies (that have commonly observed morbidity and mortality benefits associated with higher omega-3 fatty acid intakes/levels [24, 27]) and RCTs (which recently have not [9]) may have several explanations. On the one hand, the RCTs may have enrolled particularly compliant patients with higher than expected background dietary intakes of omega-3 fatty acids.…”
Section: Discussionmentioning
confidence: 99%
“…PUFA supplementation in individuals with known CAD. 48 A large-scale (n=610), randomized controlled trial called the Shunt Occlusion Trail (SOT) 49 was one of the first efforts to investigate the effect of omega-3 PUFA supplementation in patients undergoing CABG. Patients were assigned to receive either 4 g of fish oil or to the control group, while continuing antithrombotic medications (aspirin or warfarin).…”
Section: Ventricular Arrhythmiasmentioning
confidence: 99%